Oxford Metrics Reports H1 Loss Amid Strategic Shifts and Acquisitions, Backs Full-Year Outlook

The Headline Numbers: A Strategic Pause Before the Next Leap

Oxford Metrics (LSE: OMG) delivered interim results for H1 FY25 (ended 31 March 2025) that, on the surface, show a step back. Revenue dipped 14% year-on-year to £20.1m, swinging from a £3.7m statutory profit before tax in H1 FY24 to a £0.7m loss. Adjusted EBIT also landed in the red at £0.4m, compared to a £3.0m profit last year. The culprit? An exceptionally strong H1 FY24, fuelled by delivering a record order book built up during pandemic-era supply chain snarls. CEO Imogen O’Connor was clear: this wasn’t a trend expected to continue, and the dip was in line with management expectations. Crucially, the full-year outlook remains unchanged.

Digging Deeper: Why the Dip?

• Tough Comps: H1 FY24 benefited massively from clearing that pandemic backlog – including fulfilling the largest single order in company history. Customer buying patterns normalised in H2 FY24, setting a more sustainable baseline.
• Investment Phase: Significant resources were poured into launching the next-gen Vicon Markerless platform and integrating acquisitions (Sempre in H1, Amber Optix post-period).
• US Funding Headwinds: Recent policy shifts in the US led to reduced grants/funding for institutional/academic customers (a key US market segment), causing some project delays/cancellations.
• Margin Mix: Revenue growth came from the lower-margin Smart Manufacturing division (boosted by Sempre), pulling the Group gross margin down slightly to 65.5% (H1 FY24: 66.8%).

Despite the loss, the balance sheet remains a fortress. Net cash stands at £39.9m (down from £54.8m, but still substantial), bolstered by strong operating cash flow of £2.8m. This war chest funded the acquisitions (£5.5m for Sempre, £0.8m for Amber Optix), a progressive dividend hike (£4.2m paid, up from £3.6m), and a share buyback (£3.6m spent so far). Tellingly, the Board just extended the buyback by another £4m, taking the total programme to £10m – a clear signal of confidence in intrinsic value.

Motion Capture: Weathering the Storm & Planting Seeds for the Future

Revenue here fell 32% to £14.8m, mirroring the Group trend against that tough prior year comparator. Margins held up well. While the core marker-based business saw solid progress (new contracts/upgrades globally, e.g., Brazil rehab hospitals, major entertainment producers in US/Japan/Korea, Sandbox VR expansion), the real story is Vicon Markerless.

• Launched Successfully: Debuted in March 2025 at the Game Developer Conference. No suits, no markers – faster, easier motion capture.
• Positive Early Feedback: Beta tested with industry giants like Industrial Light & Magic, Gearbox, Dreamscape Immersive (who are already using it live).
• Building the Pipeline: Over 250 global demos conducted post-period. Modest FY25 revenue expected, but this is the start of a crucial new software/services revenue stream.

Regional demand is mixed: improving in South America, APAC, and Europe for Entertainment/Life Sciences, but hampered by the US funding environment.

Smart Manufacturing: The Ascent Begins

This is where the growth engine is firing. Revenue skyrocketed 194% to £5.3m, primarily fuelled by the Sempre acquisition (£3.6m contribution). Organic growth was slightly down (-3%) due to contract timing delays (since delivered). Adjusted EBIT rose to £0.7m (H1 FY24: £0.5m).

• Strategic Acquisitions: Sempre (Oct ’24) brings metrology expertise and a strong sales/service network. Amber Optix (Apr ’25, post-period) adds specialised vision inspection for contact lenses.
• Leadership: Appointed Dr Simon Gunter as dedicated MD to drive growth.
• Integration & Synergy: Key focus is merging Sempre’s distribution/commercial strength with IVS’s vision tech to create a powerful offering for coordinated manufacturing/quality environments.
• Contract Wins: Secured deals across aerospace, medical (e.g., inhaler inspection), pharma, automotive (including three Formula 1 teams).

Visibility for H2 is good, with a building order book extending beyond FY25.

Cash & Capital Allocation: Strength and Shareholder Returns

That £39.9m net cash position is the bedrock of Oxford Metrics’ strategy. It enabled the acquisitions, funds ongoing R&D (including Markerless), and supports generous shareholder returns:

• Dividend: Progressive policy continues. Final FY24 dividend of 3.25p/share (£4.2m) paid in March ’25, up from 2.75p the year before.
• Share Buyback: £3.6m spent in H1 (8.8m shares @ avg. 55p). Programme extended post-period by £4m to £10m total. Management is actively buying.
• Disciplined M&A: Focus remains on smart manufacturing bolt-ons that fit the “right acquisition, right price, right reasons” mantra. Amber Optix is the latest example.

Looking Ahead: Cautious Optimism Anchored by Strategy

The Board reaffirms FY25 Adjusted EBIT expectations, despite the H1 loss and acknowledged headwinds (US funding, macro uncertainty). Why the confidence?

• H2 Weighting: The business is traditionally second-half weighted.
• Motion Capture Pipeline: Described as “typical” across most geographies (ex-US challenges). Markerless adds a new, exciting dimension.
• Smart Manufacturing Momentum: Strong order book and pipeline visibility in this high-growth division.
• Diversification: Spread across Life Sciences, Entertainment, Engineering, and Smart Manufacturing provides resilience.
• Strong Foundation: Robust balance sheet, leading tech (Vicon), and clear strategic focus.

The journey involves navigating some near-term chop, particularly in the US academic sector. However, Oxford Metrics is actively investing in its future (Markerless, Smart Manufacturing integration & acquisitions) while rewarding shareholders. The extension of the buyback programme speaks volumes about the Board’s view of the company’s value proposition. One to watch closely as the strategic shifts and new product cycles gain traction in H2 and beyond. Keep your eyes peeled for that new three-year strategy promised with the full-year results.